Valuation: Merck KGaA

Capitalization 4.84TCr 5.67TCr 4.51TCr 4.17TCr 7.76TCr 4,85600Cr 8.68TCr 54TCr 21TCr 2,26900Cr 21TCr 21TCr 8,30100Cr P/E ratio 2025 *
15.6x
P/E ratio 2026 * 14.1x
Enterprise value 5.45TCr 6.38TCr 5.08TCr 4.7TCr 8.74TCr 5,46800Cr 9.77TCr 61TCr 23TCr 2,55500Cr 24TCr 23TCr 9,34700Cr EV / Sales 2025 *
2.52x
EV / Sales 2026 * 2.33x
Free-Float
29.72%
Yield 2025 *
2.1%
Yield 2026 * 2.18%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.44%
1 week+1.81%
Current month+2.50%
1 month-3.09%
3 months+0.27%
6 months-20.90%
Current year-19.41%
More quotes
1 week 108.5
Extreme 108.5
114.2
1 month 108.1
Extreme 108.1
116.85
Current year 108.1
Extreme 108.1
154.65
1 year 108.1
Extreme 108.1
177
3 years 108.1
Extreme 108.1
202.8
5 years 107.5
Extreme 107.5
231.5
10 years 70.68
Extreme 70.68
231.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2021
Director of Finance/CFO 55 01/07/2023
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member - 26/04/2019
Director/Board Member 62 01/05/2012
Director/Board Member 76 09/05/2014
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.44%+1.81%-24.40%-36.17% 5.67TCr
-0.86%-0.30%-19.87%-21.47% 895.39Cr
+1.40%+5.09%+7.00%+9.27% 697.18Cr
+2.63%+2.44%+23.39%+110.11% 594.22Cr
+1.19%+1.96%+16.23%+19.04% 534.36Cr
+3.13%+2.13%+85.70%-0.63% 340.05Cr
+1.81%+1.87%+22.41%+8.36% 204.58Cr
-0.18%+1.02%-7.18%+13.24% 202.86Cr
+0.50%-1.50%+42.69%-28.15% 187.44Cr
+4.88%+27.17%+188.83%-24.21% 181.5Cr
Average +1.59%+1.86%+33.48%+4.94% 950.26Cr
Weighted average by Cap. +1.36%-0.06%-5.69%-15.53%
See all sector performances

Financials

2025 *2026 *
Net sales 2.16TCr 2.53TCr 2.01TCr 1.86TCr 3.46TCr 2,16600Cr 3.87TCr 24TCr 9.16TCr 1,01200Cr 9.48TCr 9.28TCr 3,70300Cr 2.24TCr 2.62TCr 2.09TCr 1.93TCr 3.59TCr 2,24600Cr 4.01TCr 25TCr 9.5TCr 1,04900Cr 9.83TCr 9.62TCr 3,83900Cr
Net income 308.12Cr 360.71Cr 287.14Cr 265.57Cr 494.26Cr 31TCr 552.54Cr 3.44TCr 1.31TCr 14TCr 1.35TCr 1.32TCr 53TCr 340.59Cr 398.73Cr 317.4Cr 293.55Cr 546.35Cr 34TCr 610.77Cr 3.8TCr 1.45TCr 16TCr 1.5TCr 1.46TCr 58TCr
Net Debt 609.62Cr 713.67Cr 568.11Cr 525.42Cr 977.9Cr 61TCr 1.09TCr 6.8TCr 2.59TCr 29TCr 2.68TCr 2.62TCr 1,04600Cr 374.62Cr 438.56Cr 349.11Cr 322.88Cr 600.93Cr 38TCr 671.79Cr 4.18TCr 1.59TCr 18TCr 1.64TCr 1.61TCr 64TCr
More financial data * Estimated data
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.1%); - pharmaceutical products (40%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.9%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.7%), Switzerland (1.9%), Europe (22.6%), the United States (25.7%), North America (1.3%), China (13.5%), Asia/Pacific (19.6%), Latin America (7%), Middle East and Africa (3.7%).
Employees
62,604
More about the company
Date Price Change Volume
10/25/10 113.70 +2.16% 1,38,256
09/25/09 111.30 -0.27% 3,99,717
08/25/08 111.60 +2.06% 5,67,324
07/25/07 109.35 -1.71% 5,67,830
04/25/04 111.25 +0.45% 2,35,652

Delayed Quote Xetra, July 10, 2025 at 06:12 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
111.30EUR
Average target price
156.56EUR
Spread / Average Target
+40.67%
Consensus

Quarterly revenue - Rate of surprise